Dermavant Sciences: Dermavant Reports Positive Topline Resul

45.4% of subjects receiving VTAMA achieved the primary endpoint of vIGA-ADTM response of clear (0) or almost clear (1) with at least a 2-grade improvement from baseline at Week 8, versus 13.9% on

Related Keywords

, Eli Lilly , Angela Salerno Robin , Laurence Watts , Gewinn Nur , Roivant Sciences , Dermavant Sciences Gmb , Twitter , Iqvia National Prescription Audit , Dermavant Sciences Inc , Linkedin Dermavant Sciences , Dermavant Sciences , Prescribing Information , All Rights , Prescription Audit , Vice President , Media Relations , Dermavant , Ciences , Reports , Positive , Topline , Results , Rom , Adoring , Second , Topic , Dermatitis , Hase , Trial , Mtama , Tapinarof , Cream , Adults , Children , Young , Tears ,